Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Lung Cancer

Lung Cancer

An Evidence-Based Approach to Multidisciplinary Management

9780323695732
1,023.07 zł
869.61 zł Save 153.46 zł Tax included
Lowest price within 30 days before promotion: 869.61 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Care of the lung cancer patient-screening, diagnosis, and treatment-has undergone recent dramatic changes due to technologic and research-driven advances. Lung Cancer:: An Evidence-Based Approach to Multidisciplinary Management covers every aspect of this fast-changing field, including new screening guidelines, new practice standards, and new treatment advances that have led to higher survival rates. This practical, clinically oriented resource provides thorough, evidence-based coverage from experts in the field, including the increasingly important precision medicine approach in lung cancer planning and management.
Product Details
Elsevier
98506
9780323695732
9780323695732

Data sheet

Publication date
2023
Issue number
1
Cover
hard cover
Pages count
352
Dimensions (mm)
152 x 229
Weight (g)
700
  • 1. Lung Cancer Screening and Prevention
    2. Lung Cancer: Diagnostic Techniques
    3. Histology and Molecular Testing
    4. Surgical Considerations in Lung Cancer Treatment
    5. Surgically Resectable Disease
    6. Oligometastatic Disease
    7. Locally Advanced Non-Small Cell Lung Cancer
    8. First-Line Therapy
    9. Second-Line Therapy in Advanced Non-Small Cell Lung Cancer
    10. Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer: A Clinical Approach
    11. Diagnosis and Treatment of Anaplastic Lymphoma Kinase (ALK)Rearranged Non2Small Cell Lung Cancer
    12. Other Molecular Cohorts Including ROS1, BRAF, HER2, MET, NTRK, RET, KRAS
    13. Immunotherapy
    14. Small Cell Lung Cancer
Comments (0)
Viewed products